Tu Nguyen Doan Vuong is a pharmacist who is specialized in Oncology in Duarte, California. Patients can reach her at 1500 Duarte Rd, Duarte or contact her on 626-256-4673. Active license number of Tu Nguyen Doan Vuong is 78963 for Oncology in California. Tu Nguyen Doan Vuong is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Tu Nguyen Doan Vuong speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Tu Nguyen Doan Vuong
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
1500 Duarte Rd, Duarte, California, 91010-3012
Phone:
626-256-4673
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Tu Nguyen Doan Vuong are as mentioned below.
NPI Number:
1285254300
NPI Enumeration Date:
18 Apr, 2020
NPI Last Update On:
18 Apr, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Tu Nguyen Doan Vuong are as mentioned below.
Specialization
License Number
State
Status
Oncology
78963
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
9315 Bolsa Ave Unit 53, Westminster, California
Zip:
92683-5902
Phone Number:
--
Fax Number:
--
Patients can reach Tu Nguyen Doan Vuong at 1500 Duarte Rd, Duarte, California or can call on phone at 626-256-4673.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.